{"id":6759,"date":"2024-04-19T09:33:35","date_gmt":"2024-04-19T09:33:35","guid":{"rendered":"https:\/\/lupus.treefrog.dev\/lupus-canada-a-le-plaisir-dannoncer-que-sante-canada-a-approuve-evusheld-pour-la-prophylaxie-pre-exposition-a-la-covid-19-chez-les-personnes-immunodeprimees\/"},"modified":"2024-05-06T15:39:00","modified_gmt":"2024-05-06T15:39:00","slug":"lupus-canada-a-le-plaisir-dannoncer-que-sante-canada-a-approuve-evusheld-pour-la-prophylaxie-pre-exposition-a-la-covid-19-chez-les-personnes-immunodeprimees","status":"publish","type":"post","link":"https:\/\/www.lupuscanada.org\/fr\/lupus-canada-a-le-plaisir-dannoncer-que-sante-canada-a-approuve-evusheld-pour-la-prophylaxie-pre-exposition-a-la-covid-19-chez-les-personnes-immunodeprimees\/","title":{"rendered":"Lupus Canada a le plaisir d\u2019annoncer que Sant\u00e9 Canada a approuv\u00e9 Evusheld pour la prophylaxie pr\u00e9-exposition \u00e0 la COVID-19 chez les personnes immunod\u00e9prim\u00e9es."},"content":{"rendered":"\n<p>L\u2019utilisation d\u2019Evusheld est maintenant approuv\u00e9e chez les adultes et les enfants (\u00e2g\u00e9s de 12 ans et plus, pesant au moins 40 kg) qui ne sont pas actuellement infect\u00e9s par la COVID-19 et qui n\u2019ont pas eu de contact connu r\u00e9cent avec une personne infect\u00e9e par la COVID-19, et :<\/p>\n\n<ul class=\"wp-block-list\">\n<li>qui sont immunod\u00e9prim\u00e9s et peu susceptibles de d\u00e9velopper une r\u00e9ponse immunitaire ad\u00e9quate \u00e0 la vaccination contre la COVID-19\u00a0; ou<\/li>\n\n\n\n<li>pour qui la vaccination contre la COVID-19 n\u2019est pas recommand\u00e9e<\/li>\n<\/ul>\n\n<p>Pour de plus amples renseignements, veuillez consulter <a href=\"https:\/\/www.newswire.ca\/news-releases\/evusheld-tm-receives-health-canada-approval-for-pre-exposure-prophylaxis-prevention-of-covid-19-in-immune-compromised-individuals-895905857.html\" target=\"_blank\" rel=\"noopener\">le site Web suivant : EVUSHELD\u2122 RE\u00c7OIT L\u2019APPROBATION DE SANT\u00c9 CANADA POUR LA PROPHYLAXIE PR\u00c9-EXPOSITION (PR\u00c9VENTION) DE LA COVID-19 CHEZ LES PERSONNES IMMUNOD\u00c9PRIM\u00c9ES (newswire.ca)<\/a><\/p>\n\n<p>Pour consulter l\u2019\u00e9nonc\u00e9 de sant\u00e9, veuillez consulter :<\/p>\n\n<p><a href=\"https:\/\/www.canada.ca\/en\/health-canada\/news\/2022\/04\/health-canada-authorizes-evusheld-for-the-prevention-of-covid-19-in-immune-compromised-adults-and-children.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.canada.ca\/en\/health-canada\/news\/2022\/04\/health-canada-authorizes-evusheld-for-the-prevention-of-covid-19-in-immune-compromised-adults-and-children.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019utilisation d\u2019Evusheld est maintenant approuv\u00e9e chez les adultes et les enfants (\u00e2g\u00e9s de 12 ans et plus, pesant au moins 40 kg) qui ne sont pas actuellement infect\u00e9s par la COVID-19 et qui n\u2019ont pas eu de contact connu r\u00e9cent avec une personne infect\u00e9e par la COVID-19, et : Pour de plus amples renseignements, veuillez [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[92],"tags":[],"topic":[113],"audience":[121,123,122,126,125,124],"class_list":["post-6759","post","type-post","status-publish","format-standard","hentry","category-article-fr","topic-nouvelles-et-evenements","audience-ai-je-le-lupus","audience-j-ai-le-lupus","audience-j-ai-recemment-recu-un-diagnostic","audience-je-veux-plaider","audience-professionnel-de-la-sante","audience-une-personne-a-qui-je-tiens-a-le-lupus"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts\/6759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/comments?post=6759"}],"version-history":[{"count":0,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts\/6759\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/media?parent=6759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/categories?post=6759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/tags?post=6759"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/topic?post=6759"},{"taxonomy":"audience","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/audience?post=6759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}